Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 17Lymphoma, Mantle-Cell 6Lymphoma, Non-Hodgkin 4Lymphoma 3Lymphoma, Follicular 2Vomiting 1Pyloric Stenosis, Hypertrophic 1Nausea 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, B-Cell 1HIV Infections 1

Interventions

Dexamethasone 29Aprepitant 24Palonosetron 20Ondansetron 20Calcium Dobesilate 13Olanzapine 12Granisetron 11Therapeutics 7fosaprepitant 6Doxorubicin 6Cyclophosphamide 6dexamethasone acetate 5netupitant 4Vincristine 4dolasetron 3Yoga 3Tropisetron 3Surveys and Questionnaires 3Psychiatric Rehabilitation 3Prochlorperazine 3Metoclopramide 3Lorazepam 3Dronabinol 3Acupressure 3peppermint oil 2netupitant, palosentron drug combination 2ginger extract 2dexamethasone 21-phosphate 2Sugars 2Rituximab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Nausea × R-CHOP protocol × Clear all
NCT01843868 2024-08-07

Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP

Australasian Leukaemia and Lymphoma Group

Phase NA Withdrawn
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡